List of Tables
Table 1. Global Insulin Like Growth Factor I Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Insulin Like Growth Factor I Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Insulin Like Growth Factor I Market Competitive Situation by Manufacturers in 2024
Table 4. Global Insulin Like Growth Factor I Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Insulin Like Growth Factor I Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Insulin Like Growth Factor I Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Insulin Like Growth Factor I Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Insulin Like Growth Factor I Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Insulin Like Growth Factor I, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Insulin Like Growth Factor I, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Insulin Like Growth Factor I, Product Type & Application
Table 12. Global Key Manufacturers of Insulin Like Growth Factor I, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Insulin Like Growth Factor I by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Like Growth Factor I as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Insulin Like Growth Factor I Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Insulin Like Growth Factor I Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Insulin Like Growth Factor I Sales Market Share by Region (2020-2025)
Table 19. Global Insulin Like Growth Factor I Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Insulin Like Growth Factor I Sales Market Share by Region (2026-2031)
Table 21. Global Insulin Like Growth Factor I Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Insulin Like Growth Factor I Revenue Market Share by Region (2020-2025)
Table 23. Global Insulin Like Growth Factor I Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Insulin Like Growth Factor I Revenue Market Share by Region (2026-2031)
Table 25. North America Insulin Like Growth Factor I Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Insulin Like Growth Factor I Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Insulin Like Growth Factor I Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Insulin Like Growth Factor I Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Insulin Like Growth Factor I Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Insulin Like Growth Factor I Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Insulin Like Growth Factor I Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Insulin Like Growth Factor I Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Insulin Like Growth Factor I Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Insulin Like Growth Factor I Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Insulin Like Growth Factor I Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Insulin Like Growth Factor I Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Insulin Like Growth Factor I Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Insulin Like Growth Factor I Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Insulin Like Growth Factor I Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Insulin Like Growth Factor I Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Insulin Like Growth Factor I Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Insulin Like Growth Factor I Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Insulin Like Growth Factor I Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Insulin Like Growth Factor I Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Insulin Like Growth Factor I Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Insulin Like Growth Factor I Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Insulin Like Growth Factor I Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Insulin Like Growth Factor I Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Insulin Like Growth Factor I Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Insulin Like Growth Factor I Sales (K Pcs) by Type (2020-2025)
Table 51. Global Insulin Like Growth Factor I Sales (K Pcs) by Type (2026-2031)
Table 52. Global Insulin Like Growth Factor I Sales Market Share by Type (2020-2025)
Table 53. Global Insulin Like Growth Factor I Sales Market Share by Type (2026-2031)
Table 54. Global Insulin Like Growth Factor I Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Insulin Like Growth Factor I Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Insulin Like Growth Factor I Revenue Market Share by Type (2020-2025)
Table 57. Global Insulin Like Growth Factor I Revenue Market Share by Type (2026-2031)
Table 58. Global Insulin Like Growth Factor I Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Insulin Like Growth Factor I Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Insulin Like Growth Factor I Sales (K Pcs) by Application (2020-2025)
Table 61. Global Insulin Like Growth Factor I Sales (K Pcs) by Application (2026-2031)
Table 62. Global Insulin Like Growth Factor I Sales Market Share by Application (2020-2025)
Table 63. Global Insulin Like Growth Factor I Sales Market Share by Application (2026-2031)
Table 64. Global Insulin Like Growth Factor I Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Insulin Like Growth Factor I Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Insulin Like Growth Factor I Revenue Market Share by Application (2020-2025)
Table 67. Global Insulin Like Growth Factor I Revenue Market Share by Application (2026-2031)
Table 68. Global Insulin Like Growth Factor I Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Insulin Like Growth Factor I Price (USD/Pcs) by Application (2026-2031)
Table 70. Boehringer Ingelheim GmbH Company Information
Table 71. Boehringer Ingelheim GmbH Description and Business Overview
Table 72. Boehringer Ingelheim GmbH Insulin Like Growth Factor I Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Boehringer Ingelheim GmbH Insulin Like Growth Factor I Product
Table 74. Boehringer Ingelheim GmbH Recent Developments/Updates
Table 75. Genervon Biopharmaceuticals LLC Company Information
Table 76. Genervon Biopharmaceuticals LLC Description and Business Overview
Table 77. Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Product
Table 79. Genervon Biopharmaceuticals LLC Recent Developments/Updates
Table 80. MedImmune LLC Company Information
Table 81. MedImmune LLC Description and Business Overview
Table 82. MedImmune LLC Insulin Like Growth Factor I Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. MedImmune LLC Insulin Like Growth Factor I Product
Table 84. MedImmune LLC Recent Developments/Updates
Table 85. Regulaxis SAS Company Information
Table 86. Regulaxis SAS Description and Business Overview
Table 87. Regulaxis SAS Insulin Like Growth Factor I Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Regulaxis SAS Insulin Like Growth Factor I Product
Table 89. Regulaxis SAS Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Insulin Like Growth Factor I Distributors List
Table 93. Insulin Like Growth Factor I Customers List
Table 94. Insulin Like Growth Factor I Market Trends
Table 95. Insulin Like Growth Factor I Market Drivers
Table 96. Insulin Like Growth Factor I Market Challenges
Table 97. Insulin Like Growth Factor I Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Product Picture of Insulin Like Growth Factor I
Figure 2. Global Insulin Like Growth Factor I Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Insulin Like Growth Factor I Market Share by Type: 2024 & 2031
Figure 4. CIGB-845 Product Picture
Figure 5. Dusigitumab Product Picture
Figure 6. GM-6 Product Picture
Figure 7. M-610.27 Product Picture
Figure 8. M-630 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Insulin Like Growth Factor I Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Insulin Like Growth Factor I Market Share by Application: 2024 & 2031
Figure 12. Alzheimer's Disease
Figure 13. Breast Cancer
Figure 14. Huntington Disease
Figure 15. Muscular Dystrophy
Figure 16. Others
Figure 17. Global Insulin Like Growth Factor I Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Insulin Like Growth Factor I Market Size (2020-2031) & (US$ Million)
Figure 19. Global Insulin Like Growth Factor I Sales (2020-2031) & (K Pcs)
Figure 20. Global Insulin Like Growth Factor I Average Price (USD/Pcs) & (2020-2031)
Figure 21. Insulin Like Growth Factor I Report Years Considered
Figure 22. Insulin Like Growth Factor I Sales Share by Manufacturers in 2024
Figure 23. Global Insulin Like Growth Factor I Revenue Share by Manufacturers in 2024
Figure 24. Global 5 and 10 Largest Insulin Like Growth Factor I Players: Market Share by Revenue in Insulin Like Growth Factor I in 2024
Figure 25. Insulin Like Growth Factor I Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Global Insulin Like Growth Factor I Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 27. North America Insulin Like Growth Factor I Sales Market Share by Country (2020-2031)
Figure 28. North America Insulin Like Growth Factor I Revenue Market Share by Country (2020-2031)
Figure 29. U.S. Insulin Like Growth Factor I Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Canada Insulin Like Growth Factor I Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Europe Insulin Like Growth Factor I Sales Market Share by Country (2020-2031)
Figure 32. Europe Insulin Like Growth Factor I Revenue Market Share by Country (2020-2031)
Figure 33. Germany Insulin Like Growth Factor I Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. France Insulin Like Growth Factor I Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. U.K. Insulin Like Growth Factor I Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Italy Insulin Like Growth Factor I Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Russia Insulin Like Growth Factor I Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Asia Pacific Insulin Like Growth Factor I Sales Market Share by Region (2020-2031)
Figure 39. Asia Pacific Insulin Like Growth Factor I Revenue Market Share by Region (2020-2031)
Figure 40. China Insulin Like Growth Factor I Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Japan Insulin Like Growth Factor I Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. South Korea Insulin Like Growth Factor I Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. India Insulin Like Growth Factor I Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Australia Insulin Like Growth Factor I Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Taiwan Insulin Like Growth Factor I Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Indonesia Insulin Like Growth Factor I Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Thailand Insulin Like Growth Factor I Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Malaysia Insulin Like Growth Factor I Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Philippines Insulin Like Growth Factor I Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Latin America Insulin Like Growth Factor I Sales Market Share by Country (2020-2031)
Figure 51. Latin America Insulin Like Growth Factor I Revenue Market Share by Country (2020-2031)
Figure 52. Mexico Insulin Like Growth Factor I Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Brazil Insulin Like Growth Factor I Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Argentina Insulin Like Growth Factor I Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Middle East and Africa Insulin Like Growth Factor I Sales Market Share by Country (2020-2031)
Figure 56. Middle East and Africa Insulin Like Growth Factor I Revenue Market Share by Country (2020-2031)
Figure 57. Turkey Insulin Like Growth Factor I Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Saudi Arabia Insulin Like Growth Factor I Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. UAE Insulin Like Growth Factor I Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 60. Global Sales Market Share of Insulin Like Growth Factor I by Type (2020-2031)
Figure 61. Global Revenue Market Share of Insulin Like Growth Factor I by Type (2020-2031)
Figure 62. Global Insulin Like Growth Factor I Price (USD/Pcs) by Type (2020-2031)
Figure 63. Global Sales Market Share of Insulin Like Growth Factor I by Application (2020-2031)
Figure 64. Global Revenue Market Share of Insulin Like Growth Factor I by Application (2020-2031)
Figure 65. Global Insulin Like Growth Factor I Price (USD/Pcs) by Application (2020-2031)
Figure 66. Insulin Like Growth Factor I Value Chain
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
